These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11700923)

  • 21. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated administration of a F(ab')2 fragment of an anti-tumor necrosis factor alpha monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels.
    Boekstegers P; Weidenhöfer S; Zell R; Pilz G; Holler E; Ertel W; Kapsner T; Redl H; Schlag G; Kaul M
    Shock; 1994 Apr; 1(4):237-45. PubMed ID: 7735957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation.
    Windsor AC; Walsh CJ; Mullen PG; Cook DJ; Fisher BJ; Blocher CR; Leeper-Woodford SK; Sugerman HJ; Fowler AA
    J Clin Invest; 1993 Apr; 91(4):1459-68. PubMed ID: 8097206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.
    Mohler J; Azoulay-Dupuis E; Amory-Rivier C; Mazoit JX; Bédos JP; Rieux V; Moine P
    Intensive Care Med; 2003 May; 29(5):808-16. PubMed ID: 12665994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation.
    Bengtsson A; Redl H; Schlag G; Högåsen K; Götze O; Mollnes TE
    Scand J Immunol; 1998 Nov; 48(5):509-14. PubMed ID: 9822260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin.
    Cargile JL; MacKay RJ; Dankert JR; Skelley L
    Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reproduction of a model of "two-hit" sepsis model with complication of pneumonia in rat].
    Chen Y; Li H; Ma S; Deng B; Lu J; Ding F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Oct; 27(10):805-10. PubMed ID: 27132442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panax ginseng aqueous extract prevents pneumococcal sepsis in vivo by potentiating cell survival and diminishing inflammation.
    Nguyen CT; Luong TT; Lee SY; Kim GL; Kwon H; Lee HG; Park CK; Rhee DK
    Phytomedicine; 2015 Oct; 22(11):1055-61. PubMed ID: 26407948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model.
    Chudwin DS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):62-71. PubMed ID: 2491979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
    Karzai W; Cui X; Mehlhorn B; Straube E; Hartung T; Gerstenberger E; Banks SM; Natanson C; Reinhart K; Eichacker PQ
    Anesthesiology; 2003 Jul; 99(1):81-9. PubMed ID: 12826846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on the role of tumor necrosis factor-alpha in a murine model of shock due to Streptococcus pyogenes.
    Wayte J; Silva AT; Krausz T; Cohen J
    Crit Care Med; 1993 Aug; 21(8):1207-12. PubMed ID: 8339588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass.
    Vertrees RA; Tao W; Kramer GC; Nutt L; McDaniel LB; DeVine SD; Jesmok G; Zwischenberger JB
    ASAIO J; 1994; 40(3):M554-9. PubMed ID: 8555576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury.
    O'Riordain MG; O'Riordain DS; Molloy RG; Mannick JA; Rodrick ML
    J Surg Res; 1996 Jul; 64(1):95-101. PubMed ID: 8806480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group.
    Dhainaut JF; Vincent JL; Richard C; Lejeune P; Martin C; Fierobe L; Stephens S; Ney UM; Sopwith M
    Crit Care Med; 1995 Sep; 23(9):1461-9. PubMed ID: 7664546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of specific adsorbents for tumor necrosis factor-alpha and therapeutic anti-tumor necrosis factor-alpha antibodies: an in vitro sepsis model.
    Schwanzer-Pfeiffer D; Mitteregger R; Rossmanith E; Falkenhagen D
    Int J Artif Organs; 2006 Dec; 29(12):1140-7. PubMed ID: 17219354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury.
    Moore TA; Lau HY; Cogen AL; Monteleon CL; Standiford TJ
    Shock; 2003 Oct; 20(4):309-15. PubMed ID: 14501943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketamine improves survival and suppresses IL-6 and TNFalpha production in a model of Gram-negative bacterial sepsis in rats.
    Shaked G; Czeiger D; Dukhno O; Levy I; Artru AA; Shapira Y; Douvdevani A
    Resuscitation; 2004 Aug; 62(2):237-42. PubMed ID: 15294410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.
    Silva AT; Bayston KF; Cohen J
    J Infect Dis; 1990 Aug; 162(2):421-7. PubMed ID: 2373872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.